LGM
TXG icon

Logos Global Management’s 10x Genomics TXG Stock Holding History

Logos Global Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-72,831
Closed -$4.54M – 63
2020
Q1 		$4.54M Buy
+72,831
New +$5.68M 1.73% 21

Other funds holding TXG

VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Logos Global Management's TXG Position: Q2 2020 in Review

Logos Global Management sold out of 10x Genomics (TXG) in Q2 2020, closing a stake of 72,831 shares — an estimated $4.54M sold.

Logos Global Management first reported a position in TXG in Q1 2020 and held it in 1 quarter. The position peaked at $4.54M in Q1 2020. 145 funds tracked by Wall St. Rank hold TXG as of Q2 2020.

  • Logos Global Management reported no remaining 10x Genomics position as of Q2 2020 after selling out during the quarter.
  • Logos Global Management sold 72,831 10x Genomics shares in Q2 2020, an estimated $4.54M.
  • Logos Global Management first reported a position in 10x Genomics in Q1 2020 and held it in 1 quarter.
  • Logos Global Management's 10x Genomics position peaked at $4.54M in Q1 2020.
  • 145 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2020.

Based on Logos Global Management's 13F filing for Q2 2020, filed 14 Aug 2020.